Understanding Gut Microbiota Metabolites in Diabetes
Author Information
Author(s): Yao Weiguo, Huo Jinlin, Ji Jing, liu Kun, Tao Pengyu
Primary Institution: Shanghai University of Medicine & Health Sciences
Hypothesis
What is the role of gut microbiota metabolites in the regulation of diabetes?
Conclusion
Gut microbiota metabolites primarily exert their therapeutic effects on diabetes through the IL6, AKT1, and PPARG targets.
Supporting Evidence
- 48 overlapping targets between gut microbiota metabolites and diabetes were identified.
- Core targets IL6, AKT1, and PPARG were selected for diabetes treatment.
- GO analysis revealed that gut microbiota metabolites regulate oxidative stress, inflammation, and cell proliferation.
Takeaway
This study shows that the good bacteria in our gut can help manage diabetes by producing helpful substances that affect our body's insulin and inflammation.
Methodology
The study used network pharmacology to analyze gut microbiota metabolites and their targets related to diabetes.
Limitations
The study is based on data collection, and experimental validation should be carried out in future studies.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website